Arrowhead Pharma Q1 EPS $0.22 Beats $0.14 Estimate, Sales $264.033M Miss $270.066M Estimate

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.14 by 59.42 percent. This is a 115.83 percent increase over losses of $(1.39) per share from the same period last year. The company reported quarterly sales of $264.033 million which missed the analyst consensus estimate of $270.066 million by 2.23 percent. This is a 10.46K percent increase over sales of $2.500 million the same period last year.